Organogenesis Holdings Inc Cash Flow Reinvestment Rate
Organogenesis Holdings Inc cash flow reinvestment rate. Organogenesis Holdings Inc (ORGO) has a Cash Flow Reinvestment Rate of 1.45x as of September 2025, reinvesting $4.47 Million (capex $2.23 Million plus investments $-2.23 Million) from operating cash flow of $3.08 Million. See ORGO FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Organogenesis Holdings Inc (2020–2024)
Cash flow reinvestment rate of Organogenesis Holdings Inc from 2020 to 2024. Historical reinvestment intensity for Organogenesis Holdings Inc across 5 annual periods. Explore Organogenesis Holdings Inc (ORGO) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Organogenesis Holdings Inc Cash Flow Reinvestment Rate by Year (2020–2024)
Organogenesis Holdings Inc cash flow reinvestment rate by year from 2020 to 2024. Year-by-year capital reinvestment analysis for Organogenesis Holdings Inc. For the full cash flow conversion analysis, see Organogenesis Holdings Inc cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.41x | $20.06 Million | $14.21 Million | $10.03 Million | ▼ -22.1% |
| 2023 | 1.81x | $56.06 Million | $30.92 Million | $24.36 Million | ▼ -33.5% |
| 2022 | 2.73x | $67.80 Million | $24.86 Million | $33.90 Million | ▲ +170.7% |
| 2021 | 1.01x | $62.44 Million | $61.98 Million | $31.22 Million | ▼ -87.0% |
| 2020 | 7.78x | $42.51 Million | $5.47 Million | $17.68 Million | — |